Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Ocelot Bio, Inc., is a clinical-stage biopharmaceutical company dedicated to bringing meaningful therapeutic interventions to patients in dire need due to complications of decompensated (advanced) cirrhosis, in particular hepatorenal syndrome with acute kidney injury (HRS-AKI) and refractory ascites. Ocelot Bio brings new treatment options to patients with severe liver disease.

List your booth number for exhibitions, ask us